Am J Cardiol:急性冠脉综合征和缺血性卒中危险因素相似

2013-05-06 高晓方 译 医学论坛网

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖

  希腊一项研究表明,急性冠脉综合征和缺血性卒中的相关危险因素基本相似,因此有有利于同时实施一级预防措施。论文4月29日在线发表于《美国心脏病学杂志》(Am J Cardiol)。

  此项研究共纳入250例首次急性冠脉综合征患者、250例首次缺血性卒中患者以及500例基于人群的对照者;以1:1比率依据年龄和性别配对。对吸烟/被动吸烟、心血管疾病家族史、无体育活动、高血压、糖尿病、高胆固醇血症、超重和肥胖、特质焦虑以及地中海膳食依从等心血管疾病危险因素加以评估。受试者对上述危险因素的重要性认知进行分级。

  结果显示,吸烟和高胆固醇血症为效应最强的急性冠脉综合征危险因素;对于卒中而言则为焦虑和心血管疾病家族史(P 均<0.01)。对急性冠脉综合征和卒中各危险因素的比值比进行比较可发现非显著性差异,但吸烟除外。基于受试者的健康观念,吸烟和压力为最重要的危险因素,但受试者均将被动吸烟分级为次要危险因素。

原始出处:

Kastorini CM, Georgousopoulou E, Vemmos KN, Nikolaou V, Kantas D, Milionis HJ, Goudevenos JA, Panagiotakos DB.Comparative Analysis of Cardiovascular Disease Risk Factors Influencing Nonfatal Acute Coronary Syndrome and Ischemic Stroke. Am J Cardiol. 2013 Apr 26. doi:pii: S0002-9149(13)00900-4.



    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1892570, encodeId=9aba18925e034, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 05 07:22:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805963, encodeId=8a78180596315, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Feb 12 00:22:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781622, encodeId=2ade1e816228f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 18 11:22:00 CST 2013, time=2013-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430373, encodeId=6b3114303e3c1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed May 08 14:22:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1892570, encodeId=9aba18925e034, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 05 07:22:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805963, encodeId=8a78180596315, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Feb 12 00:22:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781622, encodeId=2ade1e816228f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 18 11:22:00 CST 2013, time=2013-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430373, encodeId=6b3114303e3c1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed May 08 14:22:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1892570, encodeId=9aba18925e034, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 05 07:22:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805963, encodeId=8a78180596315, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Feb 12 00:22:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781622, encodeId=2ade1e816228f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 18 11:22:00 CST 2013, time=2013-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430373, encodeId=6b3114303e3c1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed May 08 14:22:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1892570, encodeId=9aba18925e034, content=<a href='/topic/show?id=c738e93521f' target=_blank style='color:#2F92EE;'>#缺血性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79352, encryptionId=c738e93521f, topicName=缺血性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Wed Mar 05 07:22:00 CST 2014, time=2014-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1805963, encodeId=8a78180596315, content=<a href='/topic/show?id=b649e9358fa' target=_blank style='color:#2F92EE;'>#缺血性卒#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79358, encryptionId=b649e9358fa, topicName=缺血性卒)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Feb 12 00:22:00 CST 2014, time=2014-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1781622, encodeId=2ade1e816228f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Sat May 18 11:22:00 CST 2013, time=2013-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430373, encodeId=6b3114303e3c1, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Wed May 08 14:22:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

相关资讯

Am J Cardiol:GRACE评分可准确评估ACS危险

  加拿大学者的一项研究表明,与确诊急性冠脉综合征(ACS)相比,可能ACS患者的基线GRACE风险评估较高,但在入院24小时内较少接受循证性治疗。论文于2012年11月5日在线发表于《美国心脏病学杂志》(Am J Cardiol)。   此项研究共纳入16618例临床诊断为ACS的患者,并就人口统计学和临床特征、心脏操作应用、GRACE风险评分预测准确性以及院内转归对以确诊

FDA拒绝批准利伐沙班用于降低ACS患者心脏病和中风发作风险

  强生日前表示,FDA再次拒绝公司旗下利伐沙班用于降低急性冠脉综合征患者心脏病发作和卒中风险的新适应证。   利伐沙班是强生与德国制药商拜耳共同开发的一个产品,早在去年6月份利伐沙班的这一适应证就曾被FDA拒绝过,当时FDA的专家小组对该产品缺失的试验数据和出血风险表示担忧。针对这种情况,强生向FDA补充了利伐沙班临床试验中退出受试者的风险效益数据。   “虽然我们看到利伐沙班严重出血的风险

NEJM:靶向抑制血小板以澄清急性冠脉综合征的更佳药物治疗方案

  背景  对于无ST段抬高并且未进行血运重建的不稳定型心绞痛或心肌梗死患者,强化血小板抑制的效果尚未被描述。   方法  在这项双盲、随机试验中,在主要分析(包括7243例年龄<75岁且接受阿司匹林治疗的患者)中,我们评估了普拉格雷(10 mg/d)和氯吡格雷(75 mg/d)治疗长达30个月的效果比较。在次要分析(包括2083 例年龄≥75 岁的患者)中,我们评估了普拉格

NEJM:Dalcetrapib对近期有急性冠脉综合征的稳定性冠心病患者的疗效

  背景  在观察性分析中,较高水平的高密度脂蛋白胆固醇(HDL-C)与冠心病事件的较低危险相关。然而,通过治疗升高的HDL-C水平是否降低心血管危险尚不确定。抑制胆固醇酯转运蛋白(CETP)可使HDL-C水平升高,因此有可能改善心血管转归。   方法  我们随机分配15871 例近期有过急性冠脉综合征的患者,除接受最佳可用循证医疗之外,还接受600 mg/d 的CETP 抑

AHJ:TAO研究将评估奥米沙班有效性和安全性

  美国学者正在实施的TAO研究将以非ST段抬高急性冠脉综合征(NSTE-ACS)患者为受试者,并对奥米沙班的临床有效性和安全性加以评估。论文于2012年11月8日在线发表于《美国心脏杂志》(AHJ)。   奥米沙班为高选择性Xa因子直接抑制剂。一项在ACS患者中实施的临床Ⅱ期试验显示,与普通肝素(UFH)和依替巴肽相比,中等剂量奥米沙班可显著减少由死亡或心梗组成的复合终点,并且出血发生率相似。

Am Heart J:EPICOR研究有望明确ACS患者的抗血栓药物应用模式

  欧洲学者正在实施的EPICOR研究将显示急性冠脉综合征(ACS)患者住院期间和出院后的抗血栓药物应用模式,并可借此探讨不同用药模式下临床转归、生活质量和医疗费用的潜在差异。论文于2012年11月21日在线发表于《美国心脏杂志》(Am Heart J)。   前瞻性、多中心、观察性EPICOR研究对因ACS住院患者进行为期2年的出院后随访。此项研究的目的在于描述抗血栓药物应